TiGenix: Transparency notification pursuant to Article 14 of the Law of May 2, 2007

NEXT STORY
Fluidigm Introduces High-Parameter Maxpar Immune Monitoring Panel for Translational and Clinical Research
PREV STORY
Infectious Diseases a Hot Topic at the International Society for Heart and Lung Transplantation 38th Annual Meeting and Scientific Sessions
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Sanofi and Regeneron Announce Positive Phase 2 Study Results for Dupilumab in Patients With Active Moderate-to-Severe Eosinophilic Esophagitis

Sanofi and Regeneron Announce Positive Phase 2 Study Results for Dupilumab in Patients With ...

author_avatar
NASDAQ Market News

CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2018 Financial Results

-Initiated Phase 1/2 Clinical Trial of CTX001 in β-thalassemia- -Targeting Initiation of Clinical Trial for ...

author_avatar
NASDAQ Market News

Selecta Biosciences Announces Date of First Quarter 2018 Financial Results Conference Call

WATERTOWN, Mass., May 02, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ:SELB), a clinical-stage ...

author_avatar
NASDAQ Market News